Superselective Adrenal Arterial Embolization for Resistant Hypertension
Clinical trial NCT05552300 · UNKNOWN
Trial details
- NCT number
- NCT05552300
- Sponsor
- First Affiliated Hospital of Chengdu Medical College
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-10-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.